SARS-CoV-2-associated Henoch–Schönlein purpura in a 13-year-old girl

Borocco, Charlotte; Lafay, Céline; Plantard, Inès; Gottlieb, J.; Koné‐Paut, Isabelle; Galeotti, Caroline

doi:10.1016/j.arcped.2021.06.004

Cited by 15 publications

(12 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This patient was prescribed oral prednisoLONE for a month in combination with ramipril. 39 A similar case was described by Borocco et al 40 in a 13-year-old girl with a positive PCR for SARS-CoV-2 and Epstein-Barr virus. IgAV was diagnosed clinically according to EULAR/PRINTO/PRES criteria in both cases.…”

Section: Discussion Of Case Reportssupporting

confidence: 59%

COVID-19 and New Onset IgA Vasculitis: A Systematic Review of Case Reports

Messova¹,

Pivina²,

Muzdubayeva³

et al. 2022

Journal of Emergency Nursing

View full text Add to dashboard Cite

Section: Discussion Of Case Reportssupporting

confidence: 59%

COVID-19 and New Onset IgA Vasculitis: A Systematic Review of Case Reports

Messova¹,

Pivina²,

Muzdubayeva³

et al. 2022

Journal of Emergency Nursing

View full text Add to dashboard Cite

“…HSP has been observed in the setting of numerous infections and after the administration of several vaccines, including those against influenza, pneumococcal disease, rabies, hepatitis B virus, and meningococcal disease [14,15]. To date, several cases of HSP after SARS-CoV-2 infections are described in the literature [4,[16][17][18][19][20][21][22][23][24][25][26][27][28]. Recently, Obeid et coll.…”

Section: Discussionmentioning

confidence: 99%

Henoch-Schönlein Purpura Following the First Dose of COVID-19 Viral Vector Vaccine: A Case Report

et al. 2021

View full text Add to dashboard Cite

A 76 year-old female came to our observation one week after the vaccination with ChAdOx1 nCoV-19 AZD1222 for the onset of purpuric rash on her gluteal and legs regions associated with coxalgia and episodes of macrohaematuria. Henoch-Schönlein purpura (HSP) was diagnosed on the basis of the revised criteria developed by the European League Against Rheumatism, the Paediatric Rheumatology International Trials Organization, and the Paediatric Rheumatology European Society (EULAR/PRINTO/PRES). HSP is a common IgA-mediated small vessel vasculitis, typical of childhood, that affects several systems and is characterized by a tetrad of dermatological, abdominal, joint, and renal manifestations. The Etiology of HSP is not completely understood, but it was observed following upper respiratory tract infections, medications, vaccinations, and malignancies. HSP has previously been reported following immunization with various vaccines, mostly within 12 weeks post, suggesting a possible correlation. To our knowledge, this is the first report of the possible association between COVID-19 ChAdOx1 nCoV-19 AZD1222 and the onset of HSP in a previously healthy woman. No similar cases were reported amongst 23.848 participants in the ChAdOx1 nCoV-19 AZD1222 trial.

show abstract

“…Según los criterios EULAR/PRINTO/PRES, el diagnóstico se basa en la presencia de púrpura en las extremidades inferiores y en uno de cuatro criterios: dolor abdominal; histopatología (IgA); artritis o artralgia; y afectación renal. (Borocco et al, 2021). Se considera que los síntomas en el presenta caso clnico cumple con los criterios mencionado El tratamiento óptimo sigue siendo controvertido.…”

Section: Resultados Y Discusiónunclassified

Purpura de henoch scholein relacionada con uso de rivaroxaban un evento adverso infrecuente y de mecanismos aun desconocidos, descripcion de un caso

león

Sarmiento²,

Robles³

et al. 2022

Ciencia Latina

View full text Add to dashboard Cite

Introduction: Rivaroxaban is a novel direct-acting oral anticoagulant (DOAC) that is used both for the treatment and prevention of thromboembolic diseases. Due to the mechanism of action; the most common side effect can be seen with bleeding. Here we report that a patient with deep vein thrombosis of the lower limbs who presented Henoch Scholein Purpura while taking rivaroxaban. Clinical case: Female patient of the VII decade of life, was administered rivaroxaban, after intolerance to warfarin. On day 4 of the first week of treatment, the patient was admitted to the emergency department with bleeding from the oral mucosa and petechial spots. The patient was diagnosed with Henoch Scholein Purpura due to the use of rivaroxaban, after ruling out most of the possibilities. After stopping rivaroxaban treatment, the patient's bleeding symptoms subsided, the symptoms resolved completely, and her petechiae disappeared. The patient is controlled after the omission of the treatment and completely resolved the clinical picture. Conclusion: So far there are very few reports of this type when taking direct oral anticoagulants. In addition to the known side effects of rivaroxaban treatment, it should be noted that thrombocytopenia may also develop. The Naranjo scale of probability of adverse drug reaction calculated was 7 points. (probable cause of the patient's Purpura).

show abstract

SARS-CoV-2-associated Henoch–Schönlein purpura in a 13-year-old girl

Cited by 15 publications

References 9 publications

COVID-19 and New Onset IgA Vasculitis: A Systematic Review of Case Reports

COVID-19 and New Onset IgA Vasculitis: A Systematic Review of Case Reports

Henoch-Schönlein Purpura Following the First Dose of COVID-19 Viral Vector Vaccine: A Case Report

Purpura de henoch scholein relacionada con uso de rivaroxaban un evento adverso infrecuente y de mecanismos aun desconocidos, descripcion de un caso

Contact Info

Product

Resources

About